Page last updated: 2024-08-24

neocuproine and Triple Negative Breast Neoplasms

neocuproine has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alvarez, N; Batista, AA; Costa-Filho, AJ; Ellena, J; Facchin, G; Leite, CM; Mendes, LFS; Viña, D	1

Other Studies

1 other study(ies) available for neocuproine and Triple Negative Breast Neoplasms

Article	Year
Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells. Journal of inorganic biochemistry, 2020, Volume: 203 Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Chelating Agents; Coordination Complexes; Copper; Dipeptides; DNA; Humans; MCF-7 Cells; Phenanthrolines; Triple Negative Breast Neoplasms	2020

Article

Year

Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells.

Journal of inorganic biochemistry, 2020, Volume: 203

Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Chelating Agents; Coordination Complexes; Copper; Dipeptides; DNA; Humans; MCF-7 Cells; Phenanthrolines; Triple Negative Breast Neoplasms

2020